News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE)'s Kidney Cancer Drug May Not Be Effective, FDA Says



12/6/2011 6:38:17 AM

Pfizer Inc.'s advanced kidney cancer treatment may not be effective at prolonging the time some patients live without the disease getting worse, a Food and Drug Administration staff report said today.

The FDA said it was concerned that the number of U.S. patients who benefited from the therapy, chemically known as axitinib, was small. People who showed the most response were first treated with medicines known as cytokines, which are not used as much as newer treatments.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES